We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
-2.63%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.01%
AUM
$349B
AUM Growth
-$1.04B
Cap. Flow
+$12.6B
Cap. Flow %
3.6%
Top 10 Hldgs %
18.46%
Holding
3,713
New
104
Increased
2,394
Reduced
623
Closed
137

Sector Composition

Rank Sector Weight
1 Technology 22.03%
2 Healthcare 12.31%
3 Financials 11.79%
4 Consumer Discretionary 9.84%
5 Industrials 9.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QNCX icon
3551
Quince Therapeutics
QNCX
$21.5M
$12.3K ﹤0.01%
55
SFE
3552
DELISTED
Safeguard Scientifics, Inc.
SFE
$12.2K ﹤0.01%
12,218
SBEV icon
3553
Splash Beverage Group
SBEV
$2.01M
$12K ﹤0.01%
127
KULR icon
3554
KULR Technology Group
KULR
$112M
$11.8K ﹤0.01%
4,125
GNPX icon
3555
Genprex
GNPX
$3.6M
$11.7K ﹤0.01%
1
TRKA
3556
DELISTED
Troika Media Group, Inc. Common Stock
TRKA
$11.4K ﹤0.01%
10,340
NRXP icon
3557
NRX Pharmaceuticals
NRXP
$138M
$11.4K ﹤0.01%
4,373
DMRA
3558
Damora Therapeutics, Inc. Ordinary Shares
DMRA
$1.74B
$11.3K ﹤0.01%
630
RJET
3559
Republic Airways Holdings
RJET
$845M
$11.1K ﹤0.01%
859
QUBT icon
3560
Quantum Computing Inc
QUBT
$1.65B
$11K ﹤0.01%
10,216
VNRX icon
3561
VolitionRx Ltd
VNRX
$9.31M
$10.6K ﹤0.01%
769
AQB icon
3562
AquaBounty Technologies
AQB
$4.73M
$10.5K ﹤0.01%
2,202
SABS icon
3563
SAB Biotherapeutics
SABS
$266M
$10.2K ﹤0.01%
1,624
EIGR
3564
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$10.2K ﹤0.01%
1,115
ONCT
3565
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$9.78K ﹤0.01%
1,612
SUNW
3566
DELISTED
Sunworks, Inc.
SUNW
$8.97K ﹤0.01%
17,256
USBC
3567
USBC Inc
USBC
$119M
$8.76K ﹤0.01%
876
KRRO icon
3568
Korro Bio
KRRO
$145M
$8.55K ﹤0.01%
467
CTM icon
3569
Castellum
CTM
$62.9M
$7.9K ﹤0.01%
34,318
MVLA
3570
DELISTED
Movella Holdings Inc. Common Stock
MVLA
$7.89K ﹤0.01%
14,710
-110,652
-88% -$142K
TOVX icon
3571
Theriva Biologics
TOVX
$10.1M
$7.32K ﹤0.01%
543
MRDB
3572
DELISTED
MariaDB plc
MRDB
$6.64K ﹤0.01%
13,835
-126,569
-90% -$93.6K
BCEL
3573
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$5.99K ﹤0.01%
22,959
BCLI
3574
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$2.26K ﹤0.01%
752
MKUL
3575
DELISTED
Molekule Group, Inc. Common Stock
MKUL
$1.99K ﹤0.01%
13,717

Similar funds

Charles Schwab's Q3 2023 Portfolio in Review

As of Q3 2023, Charles Schwab held 3,713 positions worth $349B, down 0.3% from $350B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Charles Schwab deployed $12.6B of net new capital in Q3 2023, opening 104 new positions and adding to 2,394 existing holdings. Its largest new stake was Vanguard Value ETF: 2,862,740 shares worth $395M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Johnson & Johnson, an estimated $234M trimmed.

  • Charles Schwab's largest Q3 2023 buy was Vanguard Value ETF: 2,862,740 shares worth $395M.
  • Charles Schwab added most to iShares Core US Aggregate Bond ETF in Q3 2023, an estimated $956M increase.
  • Charles Schwab's biggest Q3 2023 reduction was Johnson & Johnson, cutting an estimated $234M.
  • Charles Schwab fully exited iShares 0-5 Year TIPS Bond ETF in Q3 2023, selling an estimated $411M.
  • Charles Schwab's ten largest holdings make up 18% of its $349B portfolio in Q3 2023.
  • Charles Schwab opened 104 new positions and closed 137 in Q3 2023.
  • Charles Schwab's portfolio value fell 0.3% quarter-over-quarter to $349B.

Based on Charles Schwab's 13F filing for Q3 2023, filed 8 Nov 2023.